Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 55 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Intravenous Access Clear all
Terminated Not applicable Interventional Accepts healthy volunteers Results available

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

NCT00914069
View directory record Official record
Conditions
Vascular Access Complication
Interventions
RIVS vascular access, Conventional vascular access
Device
Lead sponsor
C. R. Bard
Industry
Eligibility
5 Years to 90 Years
Enrollment
175 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2013
U.S. locations
3
States / cities
Fremont, California • Jacksonville, Florida • Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Apr 12, 2017 · Synced Jul 22, 2026, 8:23 PM EDT
Completed No phase listed Observational

Percentage Venous Options in Pediatrics & Adults

NCT01453335
View directory record Official record
Conditions
Veins
Interventions
Not listed
Lead sponsor
Christie Medical Holdings, Inc.
Industry
Eligibility
Not listed
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Dec 22, 2011 · Synced Jul 22, 2026, 8:23 PM EDT
Completed No phase listed Observational

Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access

NCT00935909
View directory record Official record
Conditions
IV Cannulation
Interventions
Not listed
Lead sponsor
Peter Szmuk
Other
Eligibility
Up to 18 Years
Enrollment
603 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Jun 20, 2013 · Synced Jul 22, 2026, 8:23 PM EDT
Not listed Not applicable Interventional

Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access

NCT04234347
View directory record Official record
Conditions
Venous Access
Interventions
Intravenous access method
Procedure
Lead sponsor
Temple University
Other
Eligibility
18 Years to 99 Years
Enrollment
98 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Apr 10, 2024 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Phase 2Phase 3 Interventional

Study to Reduce Intravenous Exposures (STRIVE)

NCT00391482
View directory record Official record
Conditions
Hepatitis C, HIV Infections
Interventions
Peer Mentoring Intervention for HCV-Infected IDUs
Behavioral
Lead sponsor
National Institute on Drug Abuse (NIDA)
NIH
Eligibility
18 Years to 35 Years
Enrollment
750 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2002 – 2005
U.S. locations
3
States / cities
Baltimore, Maryland • New York, New York • Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Jan 10, 2017 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional Results available

Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest

NCT01119807
View directory record Official record
Conditions
Cardiac Arrest
Interventions
Intravenous access during OHCA, Humeral IO insertion, TIbial IO insertion
Device
Lead sponsor
Wake Forest University Health Sciences
Other
Eligibility
18 Years to 110 Years
Enrollment
182 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010
U.S. locations
1
States / cities
Charlotte, North Carolina
Source: ClinicalTrials.gov public record
Updated Jun 2, 2022 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional Results available

Ultrasound-guided Peripheral IJ Study

NCT03231345
View directory record Official record
Conditions
IV Access
Interventions
US guided IJ, Ultrasound
Procedure · Device
Lead sponsor
University Medical Center of Southern Nevada
Other
Eligibility
18 Years and older
Enrollment
35 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2018
U.S. locations
1
States / cities
Las Vegas, Nevada
Source: ClinicalTrials.gov public record
Updated Jan 14, 2019 · Synced Jul 22, 2026, 8:23 PM EDT
Withdrawn Not applicable Interventional

Ultrasound Guided Peripheral Intravenous Catheter Insertion in the Hospitalized Patient: Long vs. Short Axis Placement

NCT01870661
View directory record Official record
Conditions
Need for IV Access
Interventions
Long axis IV placement with ultrasound, Short axis IV placement with ultrasound
Device
Lead sponsor
Beth Israel Medical Center
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2014
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jun 24, 2014 · Synced Jul 22, 2026, 8:23 PM EDT
Available No phase listed Expanded access

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

NCT05795361
View directory record Official record
Conditions
Hunter Syndrome
Interventions
Idursulfase-IT
Drug
Lead sponsor
Takeda
Industry
Eligibility
Male only
Healthy volunteers
Healthy volunteers not accepted
U.S. locations
17
States / cities
Phoenix, Arizona • Oakland, California • Wilmington, Delaware + 14 more
Source: ClinicalTrials.gov public record
Updated Apr 12, 2026 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Phase 1 Interventional Accepts healthy volunteers Results available

EASI Access II --- Follow-up Study to the EASI Access Trial

NCT00740727
View directory record Official record
Conditions
Disaster Medicine, Difficult Intravenous Access, Dehydration
Interventions
Human recombinant hyaluronidase (HRH), Enzymatically Augmented Subcutaneous Infusion (EASI) line placement
Drug · Procedure
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
18 Years and older
Enrollment
18 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Sep 10, 2009 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

IV SafeLock Device Functionality in Emergency Department

NCT05695183
View directory record Official record
Conditions
Intravenous Access
Interventions
IV SafeLock
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023
U.S. locations
1
States / cities
Jacksonville, Florida
Source: ClinicalTrials.gov public record
Updated Oct 9, 2023 · Synced Jul 22, 2026, 8:23 PM EDT
No Longer Available No phase listed Expanded access

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

NCT05522569
View directory record Official record
Conditions
Acute Ischemic Stroke, Mesenchymal Stem Cells, Stroke, Acute, Stroke/Brain Attack, Stroke, Ischemic
Interventions
Allogeneic human mesenchymal stem cells (Allo-hMSCs)
Drug
Lead sponsor
University of Miami
Other
Eligibility
18 Years to 80 Years
U.S. locations
1
States / cities
Miami, Florida
Source: ClinicalTrials.gov public record
Updated Apr 12, 2026 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Phase 2 Interventional Results available

Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy

NCT00607880
View directory record Official record
Conditions
Unspecified Adult Solid Tumor, Protocol Specific, Vascular Access Device Complications
Interventions
vascular access device placement
Procedure
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2009
U.S. locations
1
States / cities
Jacksonville, Florida
Source: ClinicalTrials.gov public record
Updated May 8, 2014 · Synced Jul 22, 2026, 8:23 PM EDT
Terminated Phase 3 Interventional

Veinplicity for Improved Venous Access: The VIVA Trial

NCT03752632
View directory record Official record
Conditions
Difficult-to-access Veins for Intravenous Cannulation
Interventions
Veinplicity with tourniquet, Tourniquet
Device
Lead sponsor
Physeon GmbH
Industry
Eligibility
22 Years and older
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2019
U.S. locations
3
States / cities
Plymouth, Minnesota • Rochester, Minnesota • Saint Paul, Minnesota
Source: ClinicalTrials.gov public record
Updated Oct 29, 2019 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Phase 2Phase 3 Interventional

VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access

NCT00357799
View directory record Official record
Conditions
Catheterization, Peripheral, Phlebotomy
Interventions
VeinViewer
Device
Lead sponsor
Children's Hospital and Health System Foundation, Wisconsin
Other
Eligibility
Up to 19 Years
Enrollment
170 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2010
U.S. locations
1
States / cities
Milwaukee, Wisconsin
Source: ClinicalTrials.gov public record
Updated Aug 23, 2011 · Synced Jul 22, 2026, 8:23 PM EDT
Terminated Not applicable Interventional Accepts healthy volunteers Results available

A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

NCT05204082
View directory record Official record
Conditions
Intravenous Access
Interventions
Single Use Vein Entry Indicator Device
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
Up to 18 Years
Enrollment
169 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated May 22, 2024 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional Results available

The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates

NCT02389725
View directory record Official record
Conditions
Tourniquet
Interventions
disposable elastic tourniquet, blood pressure cuff
Device
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
121 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated May 19, 2019 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional

Ultrasound Guidance for Intravenous Cannulation in Emergency Department Patients.

NCT00692549
View directory record Official record
Conditions
Difficult IV Access
Interventions
ultrasound
Device
Lead sponsor
University of California, San Francisco
Other
Eligibility
18 Years and older
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005
U.S. locations
1
States / cities
San Francisco, California
Source: ClinicalTrials.gov public record
Updated Jun 5, 2008 · Synced Jul 22, 2026, 8:23 PM EDT
Completed No phase listed Observational

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

NCT06632496
View directory record Official record
Conditions
BD Prevue II for Peripheral Intravenous Catheter Placement
Interventions
BD Prevue(TM) II
Device
Lead sponsor
Becton, Dickinson and Company
Industry
Eligibility
1 Year and older
Enrollment
156 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025
U.S. locations
2
States / cities
Brooklyn, New York • Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jan 15, 2026 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional Results available

Peripheral Intravenous Catheter Securement With Tissue Adhesive

NCT04086693
View directory record Official record
Conditions
Vascular Access Devices
Interventions
Standard IV dressing, Standard IV dressing plus a tissue adhesive peripheral IV securement device
Device
Lead sponsor
Corewell Health East
Other
Eligibility
18 Years and older
Enrollment
350 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2020
U.S. locations
1
States / cities
Royal Oak, Michigan
Source: ClinicalTrials.gov public record
Updated Dec 5, 2021 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Phase 1 Interventional Accepts healthy volunteers

A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects

NCT00991159
View directory record Official record
Conditions
Healthy
Interventions
RN316
Biological
Lead sponsor
Pfizer
Industry
Eligibility
18 Years to 70 Years
Enrollment
48 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2010
U.S. locations
2
States / cities
Phoenix, Arizona • Miami Gardens, Florida
Source: ClinicalTrials.gov public record
Updated Jul 3, 2012 · Synced Jul 22, 2026, 8:23 PM EDT
Recruiting Not applicable Interventional

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

NCT06668766
View directory record Official record
Conditions
Difficult Intravenous Access, Midline Catheter, Peripheral Intravenous Catheter, Emergency Department Patient
Interventions
10-cm Single Lumen Mildine, 4.78 cm Long Peripheral Intravenous Catheter
Device
Lead sponsor
Albany Medical College
Other
Eligibility
18 Years and older
Enrollment
270 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2027
U.S. locations
1
States / cities
Albany, New York
Source: ClinicalTrials.gov public record
Updated Jan 19, 2026 · Synced Jul 22, 2026, 8:23 PM EDT
Recruiting Phase 3 Interventional

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

NCT07525206
View directory record Official record
Conditions
Colorectal Cancer
Interventions
Telisotuzumab adizutecan, Bevacizumab, Trifluridine/Tipiracil
Drug
Lead sponsor
AbbVie
Industry
Eligibility
18 Years and older
Enrollment
700 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
3
States / cities
East Brunswick, New Jersey • Lake Success, New York • Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Jul 21, 2026 · Synced Jul 22, 2026, 8:23 PM EDT
Completed Not applicable Interventional

Ultrasound Guided IV Access in a Pediatric Emergency Department

NCT02125552
View directory record Official record
Conditions
Difficult Intravenous Access in Pediatrics
Interventions
Ultrasound guidance, Traditional intravenous access
Procedure
Lead sponsor
Children's Hospital of Philadelphia
Other
Eligibility
Up to 18 Years
Enrollment
163 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2017
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated May 14, 2018 · Synced Jul 22, 2026, 8:23 PM EDT